Advertisement
Canada markets open in 4 hours 7 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7311
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     
  • Bitcoin CAD

    87,628.23
    -3,288.48 (-3.62%)
     
  • CMC Crypto 200

    1,363.11
    -19.46 (-1.41%)
     
  • GOLD FUTURES

    2,338.90
    +0.50 (+0.02%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,499.50
    -165.00 (-0.93%)
     
  • VOLATILITY

    16.20
    +0.23 (+1.44%)
     
  • FTSE

    8,087.86
    +47.48 (+0.59%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Tilray Invests in ROSE LifeScience

On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec. The agreement between Tilray’s subsidiary High Park Farms and ROSE LifeScience entails an exclusive sale, distribution, supply, and marketing agreement. Tilray will spend 7.5 million Canadian dollars, which accounts for 12% in capital for ROSE LifeScience.